Find out about participating SARS-COV-2 seroprevalence studies.
Estimate the proportion of scholar children and adolescents with identified IgG and IgM antibodies against SARS-CoV-2
Multilocal and serial prevalence study for antibodies against SARS-2 coronavirus in Germany (MuSPAD)
The study population consist of up to 60,000 people aged 18 or older from up to 10 counties in Germany. The sampling takes place over the course of one year.